Evidence map›Paper›PMID 31954527›Full record

ReviewTrends in biotechnology2020

Gelatin Matrices for Growth Factor Sequestration.

Taneidra Buie, Joshua McCune, Elizabeth Cosgriff-Hernandez

Abstract readReview
In one paragraph

Review in Trends in biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Taneidra BuieDepartment of Biomedical Engineering, University of Texas at Austin, Austin, TX 78712, USA.
Joshua McCuneDepartment of Biomedical Engineering, University of Texas at Austin, Austin, TX 78712, USA.
Elizabeth Cosgriff-HernandezDepartment of Biomedical Engineering, University of Texas at Austin, Austin, TX 78712, USA. Electronic address: cosgriff.hernandez@utexas.edu.

Funding

Electrospun Gelatin Meshes with Multifactor Release to Promote Bone Regeneration and Prevent InfectionR03AI136060 · NIAID · UNIVERSITY OF TEXAS AT AUSTIN · PI COSGRIFF-HERNANDEZ, ELIZABETH MARIE · 2018 to 2019
$157k
NIAID NIH HHS R03 AI136060
6 · The paper itself

Abstract

Gelatin is used in a broad range of tissue engineering applications because of its bioactivity, mild processing conditions, and ease of modification, which have increased interest in its use as a growth factor delivery vehicle. Traditional methods to control growth factor sequestration and delivery have relied on controlling hydrogel mesh size via chemical crosslinking with corollary changes to the physical properties of the hydrogel. To decouple growth factor release from scaffold properties, affinity sequestration modalities have been developed to preserve the bioactivity of the growth factor through interactions with the modified gelatin. This review provides a summary of these mechanisms, highlights current gelatin growth factor delivery systems, and addresses the future perspective of gelatin matrices for growth factor delivery in tissue engineering.

Indexed as

Drug Delivery SystemsGelatinHumansHydrogelsIntercellular Signaling Peptides and ProteinsTissue EngineeringTissue ScaffoldsGelatinHydrogelsIntercellular Signaling Peptides and Proteinsaffinitycontrolled releasegelatingrowth factorsequestration

Identifiers

PMID31954527
PMCPMC11577444

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.